The purpose of this study is to determine whether women with overactive bladder (OAB) who
receive direct instillation via a catheter of a Botulinum-A Toxin (Botox) with Dimethyl
Sulfoxide (DMSO) solution experience significantly better improvement of their OAB symptoms
when compared to a similar group of women with OAB who receive instillation of DMSO only.
Phase:
Phase 3
Details
Lead Sponsor:
Mayo Clinic
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A Dimethyl Sulfoxide incobotulinumtoxinA onabotulinumtoxinA